+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Glutamine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2027-2032)

  • PDF Icon

    Report

  • 135 Pages
  • October 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6294409
The glutamine market size is expected to grow from USD 148.92 million in 2026 to USD 154.36 million in 2027 and is forecast to reach USD 196.07 million by 2032 at a 4.90% CAGR over 2027-2032. This report is Segmented by Product Type (L-Glutamine, Alanyl-Glutamine, and Other Types), Form (Powder, Capsules and Tablets, and Liquid), Application (Sports Nutrition, Dietary Supplements, Pharmaceuticals, Animal Nutrition, and Other Applications), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Glutamine Market Trends and Insights

Growth in Sports Nutrition and Fitness Participation

Rising participation in sports, fitness activities, and structured exercise is supporting demand for sports nutrition products, including amino acid-based supplements such as glutamine. According to the Sports & Fitness Industry Association (SFIA), approximately 250 million Americans participated in at least one sport, fitness, or outdoor activity in 2025, representing a 1.2% increase from the previous year. As more consumers engage in regular exercise and strength-training routines, interest in sports nutrition formulations designed to support muscle recovery and exercise performance is expanding. Glutamine is increasingly relevant to this category as it is incorporated into amino acid supplements and post-workout nutrition formulations. This is creating opportunities for glutamine manufacturers supplying supplement brands, sports nutrition producers, and specialized fitness nutrition channels.

Established Pharmaceutical Applications and Development of New Glutamine-Based Formulations

Glutamine has established applications in pharmaceutical products and specialized clinical nutrition formulations, supporting demand from pharmaceutical manufacturers and healthcare product developers. Its use in therapeutic formulations is encouraging continued research into amino acid-based treatments for specific medical conditions and supportive care applications. Pharmaceutical companies are also exploring different delivery formats and formulation approaches to improve the suitability of glutamine for specialized patient requirements. In parallel, the use of glutamine in clinical nutrition and medical preparations is strengthening its position beyond conventional dietary supplements. These applications provide manufacturers with opportunities to serve pharmaceutical, clinical nutrition, and healthcare-related end users.

Variations in Regulatory Requirements Across Pharmaceutical, Food, Feed, and Supplement Applications

Glutamine manufacturers face varying regulatory requirements depending on the intended application and target industry, creating complexities in product development, approval, and commercialization. Pharmaceutical-grade glutamine is subject to stringent quality, purity, safety, and manufacturing standards, while food and dietary supplement applications must comply with ingredient-specific regulations and labelling requirements. Similarly, its use in animal feed and companion animal nutrition is governed by separate safety and ingredient approval frameworks. These differences require manufacturers to maintain application-specific quality controls, documentation, testing procedures, and compliance systems. Navigating multiple regulatory frameworks across countries can increase operational costs, extend product development timelines, and complicate market entry.

Other drivers and restraints analyzed in the detailed report include:

  1. Growing Adoption of Specialized Nutrition and Supplements for Companion Animals
  2. Increasing Demand for Glutamine in Functional and Fortified Food Products
  3. Limited Consumer Awareness of Glutamine's Specific Benefits and Applications

Segment Analysis

L-Glutamine accounts for the largest share of the glutamine market, representing 69.37% in 2026. Its dominance is supported by its broad applicability across sports nutrition, dietary supplements, functional foods, pharmaceutical formulations, and animal nutrition. Its established use in conventional amino acid supplements and nutritional products supports consistent demand across multiple end-use industries. Additionally, its suitability for powder formulations and availability through established manufacturing processes contribute to its widespread commercial adoption. The versatility of L-Glutamine across both consumer-facing and industrial applications further reinforces its leading position within the product type segment.

Alanyl-Glutamine is projected to register the fastest growth, with a CAGR of 6.27% during 2027-2032. Its growth is supported by its application in specialized clinical nutrition, pharmaceutical formulations, and biopharmaceutical manufacturing. Compared with free-form glutamine, the dipeptide form offers greater stability in aqueous solutions, making it suitable for applications where conventional glutamine presents formulation challenges. Its use in parenteral nutrition and cell culture media also supports demand from healthcare and biotechnology manufacturers. Increasing interest in specialized amino acid formulations and the need for stable nutrient delivery systems are expected to strengthen the adoption of Alanyl-Glutamine over the forecast period.

Complete Report Scope:

  • By Product Type
    • L-Glutamine
    • Alanyl-Glutamine
    • Other Types
  • By Form
    • Powder
    • Capsules and Tablets
    • Liquid
  • By Application
    • Sports Nutrition
    • Dietary Supplements
    • Pharmaceuticals
    • Animal Nutrition
    • Other Applications
  • By Geography
    • North America
      • United States
      • Canada
      • Rest of North America
    • Europe
      • Germany
      • United Kingdom
      • Italy
      • France
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • Rest of Middle East and Africa

Geography Analysis

North America accounts for the largest share of the glutamine market, representing 34.83% in 2026. The region's leading position is supported by established sports nutrition and dietary supplement industries, widespread consumer familiarity with amino acid supplementation, and a well-developed healthcare infrastructure. Demand is further supported by the presence of pharmaceutical manufacturers, clinical nutrition providers, and established supplement brands serving diverse end-use applications. Growing interest in fitness, preventive healthcare, and specialized nutritional products is strengthening glutamine consumption across consumer and institutional channels. Additionally, established distribution networks and advanced manufacturing capabilities support the region's continued prominence in the glutamine market.

Asia-Pacific is projected to register the fastest growth in the glutamine market, with a CAGR of 6.54% during 2027-2032. Regional growth is supported by an established amino acid manufacturing base, expanding pharmaceutical and nutraceutical industries, and rising demand for sports nutrition products. China and Japan benefit from established fermentation and specialty ingredient manufacturing capabilities, while India and Southeast Asian countries are witnessing increasing adoption of dietary supplements and functional nutrition products. Growing investments in biotechnology and pharmaceutical manufacturing are further supporting demand for high-purity glutamine across industrial and healthcare applications. Additionally, the expansion of functional beverages and specialized nutritional products is creating new consumption opportunities across the region.

Europe represents the second-largest regional market, supported by established pharmaceutical, clinical nutrition, and dietary supplement industries. Demand is concentrated in major markets with developed healthcare systems and established ingredient manufacturing capabilities. South America is witnessing steady growth, supported by expanding sports nutrition consumption and rising consumer interest in health and wellness products. The Middle East and Africa region is also developing gradually, with demand supported by pharmaceutical applications, healthcare infrastructure expansion, and increasing awareness of specialized nutritional products. However, comparatively limited local manufacturing capabilities and reliance on imported ingredients continue to influence regional supply and availability.



List of Companies Covered in this Report:

  1. Ajinomoto Co., Inc.
  2. Lonza Group Ltd.
  3. Daesang Corporation
  4. Meihua Holdings Group Co., Ltd.
  5. Thermo Fisher Scientific Inc.
  6. Shijiazhuang Jirong Pharmaceutical Co., Ltd.
  7. Evonik Industries AG
  8. Glanbia plc
  9. Prinova Group LLC
  10. Merck KGaA
  11. Kyowa Hakko Bio Co., Ltd.
  12. Abbott Laboratories
  13. Nestlé Health Science
  14. Nutricia Limited
  15. MusclePharm Corporation
  16. NOW Foods
  17. NutraBio Labs, Inc.
  18. Jarrow Formulas, Inc.
  19. Designs for Health, Inc.
  20. Olimp Laboratories

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth in sports nutrition and fitness participation
4.2.2 Established pharmaceutical applications and development of new glutamine-based formulations
4.2.3 Growing adoption of specialized nutrition and supplements for companion animals
4.2.4 Increasing demand for glutamine in functional and fortified food products
4.2.5 Increasing use of functional amino acids in livestock nutrition
4.2.6 Growing demand for glutamine in biopharmaceutical manufacturing and cell culture applications
4.3 Market Restraints
4.3.1 Variations in regulatory requirements across pharmaceutical, food, feed, and supplement applications
4.3.2 Limited consumer awareness of glutamine's specific benefits and applications
4.3.3 Volatility in fermentation feedstock and manufacturing costs
4.3.4 Environmental compliance and wastewater management requirements
4.4 Value Chain Analysis
4.5 Regulatory Landscape
4.6 Porter's Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Suppliers
4.6.3 Bargaining Power of Buyers
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS (VALUE)
5.1 By Product Type
5.1.1 L-Glutamine
5.1.2 Alanyl-Glutamine
5.1.3 Other Types
5.2 By Form
5.2.1 Powder
5.2.2 Capsules and Tablets
5.2.3 Liquid
5.3 By Application
5.3.1 Sports Nutrition
5.3.2 Dietary Supplements
5.3.3 Pharmaceuticals
5.3.4 Animal Nutrition
5.3.5 Other Applications
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Rest of North America
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 Italy
5.4.2.4 France
5.4.2.5 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 India
5.4.3.3 Japan
5.4.3.4 Australia
5.4.3.5 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East and Africa
5.4.5.1 South Africa
5.4.5.2 Saudi Arabia
5.4.5.3 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Positioning Analysis
6.4 Company Profiles (includes Company Highlights, Core Segments, Financials (if available), Strategic Information, Market Share Analysis for key companies, Products, and Recent Developments)
6.4.1 Ajinomoto Co., Inc.
6.4.2 Lonza Group Ltd.
6.4.3 Daesang Corporation
6.4.4 Meihua Holdings Group Co., Ltd.
6.4.5 Thermo Fisher Scientific Inc.
6.4.6 Shijiazhuang Jirong Pharmaceutical Co., Ltd.
6.4.7 Evonik Industries AG
6.4.8 Glanbia plc
6.4.9 Prinova Group LLC
6.4.10 Merck KGaA
6.4.11 Kyowa Hakko Bio Co., Ltd.
6.4.12 Abbott Laboratories
6.4.13 Nestlé Health Science
6.4.14 Nutricia Limited
6.4.15 MusclePharm Corporation
6.4.16 NOW Foods
6.4.17 NutraBio Labs, Inc.
6.4.18 Jarrow Formulas, Inc.
6.4.19 Designs for Health, Inc.
6.4.20 Olimp Laboratories
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ajinomoto Co., Inc.
  • Lonza Group Ltd.
  • Daesang Corporation
  • Meihua Holdings Group Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Shijiazhuang Jirong Pharmaceutical Co., Ltd.
  • Evonik Industries AG
  • Glanbia plc
  • Prinova Group LLC
  • Merck KGaA
  • Kyowa Hakko Bio Co., Ltd.
  • Abbott Laboratories
  • Nestlé Health Science
  • Nutricia Limited
  • MusclePharm Corporation
  • NOW Foods
  • NutraBio Labs, Inc.
  • Jarrow Formulas, Inc.
  • Designs for Health, Inc.
  • Olimp Laboratories